Logo

Arrayit Opens New Diagnostics Marketing Division

Aug 13, 2009

NEW YORK (GenomeWeb News) – Sunnyvale, Calif.-based Arrayit is opening a business based in Houston that will serve as a commercial arm for diagnostics that will run on the company's microarray platform.

The Arrayit Diagnostics subsidiary will promote and market tests using the microarray platform that are aimed at early-stage diagnostics. Arrayit currently is developing diagnostic tests for cancer, neurodegenerative disease, and other diseases.

The company said that Arrayit Diagnostics will launch an "intensive" marketing campaign supported by a network of 41 international life science and diagnostic distributors in 38 countries.

Filed under

Diagnostics
Arrayit
Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.